SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies

Valdes-Balbin, Y; Santana-Mederos, D; Quintero, L; Fernandez, S; Rodriguez, L; Ramirez, BS; Perez-Nicado, R; Acosta, C; Mendez, Y; Ricardo, MG; Hernandez, T; Bergado, G; Pi, F; Valdes, A; Carmenate, T; Ramirez, U; Oliva, R; Soubal, JP; Garrido, R; Cardoso, F; Landys, M; Gonzalez, H; Farinas, M; Enriquez, J; Noa, E; Suarez, A; Fang, C; Espinosa, LA; Ramos, Y; Gonzalez, LJ; Climent, Y; Rojas, G; Relova-Hernandez, E; Infante, YC; Losada, SL; Boggiano, T; Ojito, E; Leon, K; Chiodo, F; Paquet, F; Chen, GW; Rivera, DG; Garcia-Rivera, D; Bencomo, VV

Valdes-Balbin, Y; Garcia-Rivera, D; Bencomo, VV (corresponding author), Finlay Vaccine Inst, Havana 11600, Cuba.

ACS CHEMICAL BIOLOGY, 2021; 16 (7): 1223

Abstract

Controlling the global COVID-19 pandemic depends, among other measures, on developing preventive vaccines at an unprecedented pace. Vaccines approved ......

Full Text Link